我們將使用cookie等資訊來優化您的體驗,繼續瀏覽即表示您同意我們使用。欲瞭解詳細內容,請詳閱
隱私權保護政策
×
聯亞生技
SEARCH:
關於我們
關於聯亞
創辦人暨董事長的話
榮耀與沿革
堅實經營團隊
產品介紹
人用疫苗
UB-612 COVID疫苗
UB-211 抗IgE疫苗
抗IL-6人用疫苗
動物疫苗
豬隻免疫去勢疫苗
O型口蹄疫合成胜肽疫苗
核心技術
UBITh®設計型疫苗
脂蛋白設計型疫苗
最新消息
公司公告
消息發布
UB-612廣譜新冠疫苗精選
期刊論文
全球據點
影片專區
我們有話要說
UB-612廣譜新冠疫苗精選
聯絡我們
期刊論文
首頁
期刊論文
全部期刊論文
期刊論文
View More
28
06
2023
Targeting Multiple Conserved T-Cell Epitopes for Protection against COVID-19 Moderate-Severe Disease by a Pan-Sarbecovirus Vaccine
廣譜新冠疫苗UB-612靶向多重T細胞保守表位,針對中重症新冠肺炎提供有效保護力
more
Targeting Multiple Conserved T-Cell Epitopes for Protection against COVID-19 Moderate-Severe Disease by a Pan-Sarbecovirus Vaccine
View More
20
04
2023
Toward a Pan-SARS-CoV-2 vaccine targeting conserved epitopes on spike and non-spike proteins for potent, broad and durable immune responses
新冠疫苗UB-612針對棘突/非棘突蛋白之保守表位誘導有效、廣譜、且長效的免疫反應
more
Toward a Pan-SARS-CoV-2 vaccine targeting conserved epitopes on spike and non-spike proteins for potent, broad and durable immune responses
View More
26
10
2022
A Novel RBD-Protein/Peptide Vaccine Elicits Broadly Neutralizing Antibodies and Protects Mice and Macaques against SARS-CoV-2
新型RBD蛋白/胜肽多重表位次單位疫苗可誘發廣譜中和性抗體並保護小鼠與靈長類動物免於SARS-CoV-2感染
more
A Novel RBD-Protein/Peptide Vaccine Elicits Broadly Neutralizing Antibodies and Protects Mice and Macaques against SARS-CoV-2
View More
15
10
2022
High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster UB-612
疫苗追加劑可誘導針對嚴重急性呼吸道症候群冠狀病毒2型Omicron BA.1與BA.2高效價的中和抗體
more
High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster UB-612
View More
30
08
2022
UB-612 Multitope Vaccine targeting both Spike and Non-Spike Proteins of SARS-CoV-2 Provides Broad and Durable Immune Responses
多重表位次單位疫苗UB-612可靶向SARS-CoV-2棘突與非棘突蛋白產生廣譜且持續的免疫反應
more
UB-612 Multitope Vaccine targeting both Spike and Non-Spike Proteins of SARS-CoV-2 Provides Broad and Durable Immune Responses
View More
05
05
2022
UB-612, a Multitope Universal Vaccine Eliciting a Balanced B and T Cell Immunity against SARS-CoV-2 Variants of Concern
多重表位次單位廣譜疫苗UB-612誘導平衡之B細胞與T細胞免疫反應對抗SARS-CoV-2變異株
more
UB-612, a Multitope Universal Vaccine Eliciting a Balanced B and T Cell Immunity against SARS-CoV-2 Variants of Concern
View More
22
03
2022
A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants
多重表位次單位疫苗UB-612誘導B細胞與T細胞的長效免疫反應以對抗Delta/Omicron變異株
more
A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants
View More
18
10
2021
Potent Anti-Delta Effect By a Booster Third-Dose of UB-612, a Precision-Designed SARS-CoV-2 Multitope Protein-Peptide Vaccine
多重表位次單位精準設計疫苗UB-612作為追加劑具抗Delta變異株潛力
more
Potent Anti-Delta Effect By a Booster Third-Dose of UB-612, a Precision-Designed SARS-CoV-2 Multitope Protein-Peptide Vaccine
View More
07
10
2021
A Novel SARS-CoV-2 RBD-Protein/T Cell Peptide Multitope Vaccine Elicited Neutralizing Antibodies against Multiple Variants of Concerns: T cell Immunity and Protection Against Respiratory Infection in Mice and Non-Human Primates
新型SARS-CoV-2 RBD蛋白/T細胞胜肽多重表位次單位疫苗可誘發對抗多種變異株之中和抗體: T細胞免疫和在小鼠與靈長類動物中對抗呼吸道感染的效果
more
A Novel SARS-CoV-2 RBD-Protein/T Cell Peptide Multitope Vaccine Elicited Neutralizing Antibodies against Multiple Variants of Concerns: T cell Immunity and Protection Against Respiratory Infection in Mice and Non-Human Primates
TAG
相關標籤
UB-612
新冠疫苗
王長怡
產品搜尋
回首頁
SEARCH:
關於我們
關於聯亞
創辦人暨董事長的話
榮耀與沿革
堅實經營團隊
產品介紹
人用疫苗
UB-612 COVID疫苗
UB-211 抗IgE疫苗
抗IL-6人用疫苗
動物疫苗
豬隻免疫去勢疫苗
O型口蹄疫合成胜肽疫苗
核心技術
UBITh®設計型疫苗
脂蛋白設計型疫苗
最新消息
公司公告
消息發布
UB-612廣譜新冠疫苗精選
期刊論文
全球據點
影片專區
我們有話要說
UB-612廣譜新冠疫苗精選
聯絡我們
03-5984151
https://www.youtube.com/channel/UCpfpMwqQTWerYoiWqxyFcnQ
PR@ubiasia.com